Clinical Trial IDNCT04169360
Lead SponsorUniversity of Maryland, Baltimore
Principal Investigator
Start Date2020-01-01
Completion Date2021-05-01
Study TypeInterventional
PhasePhase 2
StatusNot yet recruiting

Purpose

This is a double blind, placebo controlled, randomized trial to evaluate the safety and preliminary efficacy of ANS-6637 in adults with opioid use disorder with and without opioid agonist therapy. Patients will be randomized to two arms: (1) ANS-6637 for three months vs (2) Placebo for three months. Subjects will subsequently be followed for an additional one month post treatment.

Conditions

ConditionInterventionPhase
Opioid-use DisorderDrug: ANS-6637, Drug: Placebo oral tabletPhase 2

Eligibility

AgeGenderAccepts Healthy Volunteers
18 Years to 65 YearsAllNo